|Last Price$50.69||Day Change (%)-0.16%|
|Open Price$51.07||Day Change ($)-0.08|
|Day Range50.60–51.13||52-Week Range39.28–51.74|
As of Fri 7/31/2015 6:54:00 PM | USD
Abbott Labs Profit Beats Expectations
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Simple formulas for foreign exposure lose luster.
Abbott Reports Second-Quarter 2015 Results
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
Research and Markets: Anal Fissure - Global Clinical Trials Review, H1, 2015
Research and Markets: Acidity Clinical Trials - Global Review, H1, 2015
Research and Markets: The Market for Clinical Chemistry to 2019
AbbVie Reports Second-Quarter 2015 Financial Results
St. Jude Medical to Buy Thoratec for $3.4 Billion -- 2nd Update